Timolol eye drops
قطره تیمولول
👁️ Sensory OrgansOphthalmic beta-blocker
Market / country: 🇺🇸 USA
Timoptic (US)
🧮 Dose calculator
Open-angle glaucoma / ocular hypertension · Regimen source: FDA Timolol eye · Dosage and Administration
- • If not adequate, 1 drop of 0.5% twice daily. FDA Timolol eye · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Asthma or history of asthma; severe COPD; sinus bradycardia; 2nd/3rd-degree AV block; overt heart failure; cardiogenic shock; hypersensitivity. FDA Timolol eye · Contraindications
Formulations
- 0.25% ophthalmic solution — eye drops 🇺🇸 USA FDA Timolol eye · How Supplied
- 0.5% ophthalmic solution — eye drops 🇺🇸 USA FDA Timolol eye · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Timolol eye · Pregnancy:
“Timolol maleate ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Timolol eye · Nursing Mothers
“Because of the potential for serious adverse reactions from timolol maleate ophthalmic solution in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Timolol eye · Pediatric Use
“Safety and effectiveness of timolol maleate ophthalmic solution have been established when administered in pediatric patients aged 2 years and older.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Timolol eye · Geriatric Use
“No overall differences in safety or effectiveness have been observed between elderly and younger patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA077259
- DailyMed (FDA label)FDA Timolol eye
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDS01ED01
- Darooyab (Iran)Timolol
🇮🇷 Registered in Iran Darooyab · G-1908/Timolol
Dosage forms with Iranian generic codes, per Darooyab.
- 01226 · TIMOLOL MALEATE 0.5% 5ML OPH DROP · قطره چشمی تیمولول مالئات ۰٫۵ درصد ۵ میلیلیتر
- 01695 · TIMOLOL MALEATE 10MG TAB · قرص تیمولول مالئات ۱۰ میلیگرم
- 01227 · TIMOLOL MALEATE 5MG TAB · قرص تیمولول مالئات ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Timolol eye · How SuppliedFDA Timolol eye · Dosage and AdministrationFDA Timolol eye · ContraindicationsFDA Timolol eye · Pregnancy:FDA Timolol eye · Nursing MothersFDA Timolol eye · Pediatric UseFDA Timolol eye · Geriatric UseFDA Timolol eye · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1908/Timolol
- Clinical review⚠ Unverified